Ken Fisher's GLUE Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 314,862 shares of Monte Rosa Therapeutics, Inc. (GLUE) worth $5.18 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ken Fisher has initiated a new position in GLUE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Monte Rosa Therapeutics (GLUE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Monte Rosa Therapeutics (GLUE) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +314,862 | New Buy | 314,862 | $16.45 |
Ken Fisher's Monte Rosa Therapeutics Investment FAQs
Ken Fisher first purchased Monte Rosa Therapeutics, Inc. (GLUE) in Q1 2026, acquiring 314,862 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Monte Rosa Therapeutics, Inc. (GLUE) for 1 quarters since Q1 2026.
Ken Fisher's largest addition to Monte Rosa Therapeutics, Inc. (GLUE) was in Q1 2026, adding 314,862 shares worth $5.18 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 314,862 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $5.18 M.
As of the Q1 2026 filing, Monte Rosa Therapeutics, Inc. (GLUE) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Monte Rosa Therapeutics, Inc. (GLUE) was 314,862 shares, as reported at the end of Q1 2026.